HRP20170711T1 - Kontinuirani postupak za alkilaciju cikličnih tercijarnih amina - Google Patents

Kontinuirani postupak za alkilaciju cikličnih tercijarnih amina Download PDF

Info

Publication number
HRP20170711T1
HRP20170711T1 HRP20170711TT HRP20170711T HRP20170711T1 HR P20170711 T1 HRP20170711 T1 HR P20170711T1 HR P20170711T T HRP20170711T T HR P20170711TT HR P20170711 T HRP20170711 T HR P20170711T HR P20170711 T1 HRP20170711 T1 HR P20170711T1
Authority
HR
Croatia
Prior art keywords
solution
bromide
alkaline agent
methyl
cyclo
Prior art date
Application number
HRP20170711TT
Other languages
English (en)
Inventor
Andrea Mereu
Moreno Morosoli
Mauro Perseghini
Alessandro Spreafico
Original Assignee
Cerbios-Pharma S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cerbios-Pharma S.A. filed Critical Cerbios-Pharma S.A.
Publication of HRP20170711T1 publication Critical patent/HRP20170711T1/hr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D451/00Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/12Oxygen or sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56Ring systems containing three or more rings
    • C07D209/80[b, c]- or [b, d]-condensed
    • C07D209/94[b, c]- or [b, d]-condensed containing carbocyclic rings other than six-membered
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D451/00Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • C07D451/04Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
    • C07D451/06Oxygen atoms
    • C07D451/12Oxygen atoms acylated by aromatic or heteroaromatic carboxylic acids, e.g. cocaine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrrole Compounds (AREA)

Claims (19)

1. Postupak za kontinuiranu alkilaciju ciklličnih tercijarnih amina koji sadrži: - kontinuirano napajanje otopine cikličkog tercijarnog amina u pogodnoj otopini ili smjesi otopine i sredstva za alkilaciju, otopljenog u pogodnoj otopini ili smjesi otopine koje su aprotonske otopine odabrane od amida, nitrila i sulfoksida, u reaktor s kontinuiranim protokom; - održavanje temperature unutar opsega od 20-200°C; - sakupljanje otopine koja sadrži čisti kvaternarni ciklički amonijski spoj; - izolaciju čistog kvaternarnog cikličkog amonijskog spoja, pri čemu, navedeni ciklički tercijarni amini i kvaternarna ciklički amonijski spojevi su spojevi opće formule [image] respektivno, gdje R je linearna ili granata C1-C12 alkil skupina; R1 je linearna ili granata C1-C3 alkil skupina; X je atom halogena ili karbonat, sulfat ili triflat; i A je radikal koji tvori odabrano supstituiran monocikličan, bicikličan ili tricikličan prsten s atomom dušika, pri čemu je navedeni prsten odabran od odabrano supstituiranih monocikličnih prstenova koj imaju od 4 do 7 atoma, odabrano uključujući 1 ili 2 heteroatoma odabrano od N, O i S, pored atoma dušika za koji su vezani; odabrano supstituiranih bicikličnih prstenova koji imaju od 6 do 9 atoma, odabrano uključujući 1 ili 2 heteroatoma odabrana od N, O i S, pored atoma dušika za koji su vezani; i odabrano supstituiranog tricikličnog prstena koji ima od 8 do 12 atoma, odabrano uključujući 1 ili 2 heteroatoma odabran od N, O i S, pored atoma dušika za koji su vezani.
2. Postupak u skladu s patentnim zahtjevom 1, naznačen time što R je C1-C4 alkil skupina.
3. Postupak u skladu s patentnim zahtjevom 2, naznačen time što R je metil ili izopropil.
4. Postupak u skladu s patentnim zahtjevom 1 naznačen time što R1 je metil.
5. Postupak u skladu s patentnim zahtjevom 1, naznačen time što navedeni monociklični, biciklični i triciklični prstenovi su prstenovi formule [image] i odgovarajuće kvaternarne amonijske soli [image] gdje R, R1 i X imaju gore prikazana značenja i Y je supstituent odabran iz (ciklo)alkil, aril, heteroaril, arilalkil, heteroarilalkil, (ciklo)alkoksi, ariloksi, heteroariloksi, (ciklo)alkilkarbonil, arilkarbonil, heteroarilkarbonil, (ciklo)alkilkarboniloksi, arilkarboniloksi, heteroarilkarboniloksi, arilalkilkarboniloksi, i heteroarilalkilkarboniloksi.
6. Postupak u skladu s patentnim zahtjevom 5, naznačen time što Y je odabran iz (ciklo)alkilkarboniloksi, arilalkilkarboniloksi i heteroarilalkilkarboniloksi skupine.
7. Postupak u skladu s patentnim zahtjevom 6, naznačen time što Y je skupina formule: [image] gdje R2, R3 i R4, isti ili različiti, su vodik, hidroksi, hidroksialkil, poželjno hidroksimetil, fenil, cikloalkil, poželjno ciklopentil, i heteroaril, poželjno tienil.
8. Postupak u skladu s patentnim zahtjevom 1, naznačen time što je alkalno sredstvo spoj formule R1X gde R1 i X imaju gore navedena značenja.
9. Postupak u skladu s patentnim zahtjevom 8, naznačen time što je alkalno sredstvo spoj formule R1X gdje X je atom halogena odabran iz Cl, Br i I.
10. Postupak u skladu s patentnim zahtjevom 9, naznačen time što je alkalno sredstvo odabrano iz metil klorida, metil bromida, metil jodida, etil klorida, etil bromida, etil jodida, n-propil klorida, n-propil bromida, n-propil jodida, izopropil klorida, izopropil bromida i izopropil jodida.
11. Postupak u skladu s patentnim zahtjevom 10, naznačen time što alkalno sredstvo je metil bromid.
12. Postupak u skladu s patentnim zahtjevom 1, naznačen time što je navedena polarna aprotonska otopina odabrana iz acetonitrila, dimetilformamida, dimetilacetamida, N-metilpirolidona i dimetilsulfoksida.
13. Postupak u skladu s patentnim zahtjevom 1, naznačen time što je alkalno sredstvo uvedeno čisto u reaktor s kontinuiranim protokom.
14. Postupak u skladu s patentnim zahtjevom 1, naznačen time što je alkalno sredstvo uvedeno u reaktor s kontinuiranim protokom kao otopina, odabrano prethodno pomješan s otopinom cikličnog tercijarnog amina.
15. Postupak u skladu s patentnim zahtjevom 14, naznačen time što je otopina za pripremu otopine alkalnog sredstva acetonitril.
16. Postupak u skladu s patentnim zahtjevom 1, naznačen time što je otopina za otapanje cikličnog tercijarnog amina odabrana iz dimetilacetamida, dimetilsulfoksida i N-metilpirolidona.
17. Postupak u skladu s patentnim zahtjevom 16, naznačen time što je otopina N-metilpirolidon.
18. Postupak u skladu s patentnim zahtjevom 1, naznačen time što je temperatura u opsegu od 20 do 200°C, poželjno od 40 do 85°C.
19. Postupak u skladu s bilo kojim od prethodnih patentnih zahtjeva za pripremu tiotropij bromida, glikopironij bromida i ipratropij bromida.
HRP20170711TT 2011-12-22 2017-05-12 Kontinuirani postupak za alkilaciju cikličnih tercijarnih amina HRP20170711T1 (hr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP11195419.4A EP2607351B1 (en) 2011-12-22 2011-12-22 Continuous process for the alkylation of cyclic tertiary amines

Publications (1)

Publication Number Publication Date
HRP20170711T1 true HRP20170711T1 (hr) 2017-07-28

Family

ID=45445872

Family Applications (1)

Application Number Title Priority Date Filing Date
HRP20170711TT HRP20170711T1 (hr) 2011-12-22 2017-05-12 Kontinuirani postupak za alkilaciju cikličnih tercijarnih amina

Country Status (19)

Country Link
US (1) US8865903B2 (hr)
EP (1) EP2607351B1 (hr)
JP (1) JP6045320B2 (hr)
CN (1) CN103172481B (hr)
AU (1) AU2012244237B2 (hr)
BR (1) BR102012032754B8 (hr)
CA (1) CA2793619C (hr)
CY (1) CY1118937T1 (hr)
DK (1) DK2607351T3 (hr)
ES (1) ES2625498T3 (hr)
HR (1) HRP20170711T1 (hr)
HU (1) HUE034540T2 (hr)
IL (1) IL223230B (hr)
LT (1) LT2607351T (hr)
PL (1) PL2607351T3 (hr)
PT (1) PT2607351T (hr)
RS (1) RS55996B1 (hr)
RU (1) RU2614412C2 (hr)
SI (1) SI2607351T1 (hr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2789611A1 (en) * 2013-04-08 2014-10-15 Cerbios-Pharma S.A. A crystalline form of tiotropium bromide
CN106831753B (zh) * 2017-01-10 2019-02-22 武汉先路医药科技股份有限公司 一种异丙托溴铵的合成方法
CN108911994A (zh) * 2018-06-11 2018-11-30 上海华银日用品有限公司 一种环保长链烷基季铵盐溶液及其连续制备方法
RU2677273C1 (ru) * 2018-07-30 2019-01-16 Федеральное государственное бюджетное образовательное учреждение высшего образования "Чувашский государственный университет имени И.Н. Ульянова" Способ получения четвертичных аммониевых соединений метил дицианоацетата
CN110183438A (zh) * 2019-05-17 2019-08-30 南京望知星医药科技有限公司 一种异丙托溴铵的制备方法
PT115583B (pt) 2019-06-17 2022-05-02 Hovione Farm S A Processo contínuo para a preparação de medicamentos anticolinérgicos
CN111269226B (zh) * 2020-04-13 2021-09-21 石家庄四药有限公司 异丙托溴铵的合成方法
CN111978316B (zh) * 2020-08-21 2021-06-04 华润双鹤药业股份有限公司沧州分公司 一种异丙托溴铵的合成方法

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2956062A (en) 1959-02-26 1960-10-11 Robins Co Inc A H Esters of amino alcohols
NL172322C (nl) 1969-02-25 1983-08-16 Hoechst Ag Werkwijze voor het bereiden van quaternaire ammoniumverbindingen.
JPS58174349A (ja) * 1982-04-08 1983-10-13 Yotsukaichi Gosei Kk 3−クロル−2−オキシプロピルトリメチルアンモニウムクロライド水溶液の製造法
DE3713996A1 (de) 1987-04-27 1988-11-10 Henkel Kgaa Verfahren zur herstellung von quartaeren ammoniumhalogeniden
US5610163A (en) 1989-09-16 1997-03-11 Boehringer Ingelheim Gmbh Esters of thienyl carboxylic acids and amino alcohols and their quaternization products
DE3931041C2 (de) * 1989-09-16 2000-04-06 Boehringer Ingelheim Kg Ester von Thienylcarbonsäuren mit Aminoalkoholen, ihre Quaternierungsprodukte, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
US5041664A (en) 1990-07-23 1991-08-20 Texaco Chemical Company Continuous process for preparing quaternary ammonium salts
JP2886990B2 (ja) * 1990-12-20 1999-04-26 三井化学株式会社 不飽和第四級アンモニウム塩の製造方法
US5491240A (en) 1994-09-29 1996-02-13 Witco Corporation Quaternary compound of a tertiary amine and methyl chloride
DE69724967D1 (de) * 1996-04-24 2003-10-23 Novo Nordisk As Heterozyklische verbindungen, ihre herstellung und ihre anwendung
EP0869114A1 (en) 1997-04-04 1998-10-07 Dow Europe S.A. Composition useful for softening applications and processes for the preparation thereof
JP4774604B2 (ja) * 2000-02-14 2011-09-14 和光純薬工業株式会社 第4級アンモニウム塩の製造方法
DE10064816A1 (de) * 2000-12-22 2002-06-27 Boehringer Ingelheim Pharma Verfahren zur Herstellung eines Anticholinergikums
FR2824062B1 (fr) * 2001-04-27 2004-10-15 Atofina Procede de fabrication de solutions aqueuses de sels insatures d'ammonium quaternaire
US6610849B2 (en) * 2001-06-28 2003-08-26 Boehringer Ingelheim Pharma Kg Process for the manufacture of tropenol
SE0104346L (sv) * 2001-12-21 2003-06-22 Akzo Nobel Nv Process för kontinuerlig kvartärnering av tertiära aminer med en alkylhalid
JP4178837B2 (ja) * 2002-05-29 2008-11-12 東亞合成株式会社 ジアルキルアミノアルキル(メタ)アクリレート4級塩の製造方法
JP4062055B2 (ja) * 2002-11-01 2008-03-19 東亞合成株式会社 ジアルキルアミノアルキル(メタ)アクリレート4級塩の製造方法
AT412088B (de) * 2002-12-18 2004-09-27 Pharmacon Forschung & Beratung Gmbh Verfahren zur herstellung der r,r oder s,s konfigurierten glycopyrronium-isomere
US8247597B2 (en) 2010-01-21 2012-08-21 Nalco Company Continuous production of DMAEA quaternary salts

Also Published As

Publication number Publication date
RU2012152600A (ru) 2014-06-20
CA2793619A1 (en) 2013-06-22
DK2607351T3 (en) 2017-06-06
RS55996B1 (sr) 2017-09-29
US8865903B2 (en) 2014-10-21
ES2625498T3 (es) 2017-07-19
CY1118937T1 (el) 2018-01-10
BR102012032754A2 (pt) 2013-11-12
AU2012244237B2 (en) 2016-11-03
HUE034540T2 (en) 2018-02-28
PT2607351T (pt) 2017-05-26
RU2614412C2 (ru) 2017-03-28
BR102012032754B8 (pt) 2021-03-23
EP2607351B1 (en) 2017-03-15
CA2793619C (en) 2019-02-05
AU2012244237A1 (en) 2013-07-11
JP6045320B2 (ja) 2016-12-14
JP2013133335A (ja) 2013-07-08
CN103172481B (zh) 2017-05-10
EP2607351A1 (en) 2013-06-26
PL2607351T3 (pl) 2017-08-31
US20130165656A1 (en) 2013-06-27
BR102012032754B1 (pt) 2020-12-29
LT2607351T (lt) 2017-06-12
IL223230B (en) 2018-02-28
SI2607351T1 (sl) 2017-07-31
CN103172481A (zh) 2013-06-26

Similar Documents

Publication Publication Date Title
HRP20170711T1 (hr) Kontinuirani postupak za alkilaciju cikličnih tercijarnih amina
HRP20200538T1 (hr) Derivati pirimidina za liječenje virusnih infekcija
AU2007220419B2 (en) Selective androgen receptor modulators
HRP20160533T1 (hr) Indoli kao antivirusna sredstva respiratornog sincicijskog virusa
HRP20201433T1 (hr) Supstituirani (e)-n´- (1-feniletiliden) analozi benzohidrazida kao inhibitori histonske demetilaze
MX2011010647A (es) Analogos de isoxasol-3 (2h)-ona como agentes terapeuticos.
IL263543A (en) Methods and devices for synthesizing imaging agents, and their intermediates
ES2587903T3 (es) Compuestos de imidazolidinadiona y sus usos
IL259610A (en) A method for synthesizing analogues of the thyroid hormone and their polymorphs
MX343288B (es) Proceso para la preparación de derivados de quinolina.
HRP20211973T1 (hr) Kinazolini kao inhibitori ionskih kalijskih kanala
RS53176B (en) KINASE INHIBITORS 1 REGULATING SIGNALS IN APOPTOSIS
HRP20220628T1 (hr) Postupci i međuprodukti za pripremu lijeka
MX2012009076A (es) Composiciones de combustible.
HRP20220750T1 (hr) Postupak za proizvodnju spoja diariltiohidantoina
NZ627036A (en) Piperidino-pyrimidine derivatives for the treatment of viral infections
RU2014141579A (ru) Гетероциклические соединения в качестве ингибиторов бета-лактамаз
AR093725A1 (es) Quinazolincarboxamida azetidinas
JP2011510970A5 (hr)
HRP20192109T1 (hr) Novi spoj i proces
JO3143B1 (ar) مركبات تتراهيدرو بيرولو ثيازين
HRP20160001T1 (hr) Postupak za pripravu fenil supstituiranih n-metoksi-[1-metil-2-feniletil]amida 3-difluorometil-1-metil-1h-pirazol-4-karboksilne kiseline
NZ701721A (en) Amides of 2-amino-4-arylthiazole compounds and their salts
MA39715A (fr) Formes polymorphes de l&#39;acide 4,5-dihydro-1h-pyrrolo[2,3-f]quinoline-2,7,9-tricarboxylique et de son sel de disodium, procédé de préparation desdites formes polymorphes et leur utilisation
HRP20170416T1 (hr) Sintetski postupci i postupci pročišćavanja spojeva fosfaplatine i njihova uporaba